Behavioral and transcriptome alterations in male and female mice with postnatal deletion of TrkB in dorsal striatal medium spiny neurons. by Unterwald, Ellen M et al.
Thomas Jefferson University
Jefferson Digital Commons
Faculty papers Farber Institute for Neurosciences Farber Institute for Neurosciences
1-1-2013
Behavioral and transcriptome alterations in male
and female mice with postnatal deletion of TrkB in
dorsal striatal medium spiny neurons.
Ellen M Unterwald
Temple University School of Medicine
Michelle E. Page
Thomas Jefferson University, michelle.page@jefferson.edu
Timothy B Brown
Thomas Jefferson University, timothy.brown@mssm.edu
Jonathan S Miller
Temple University School of Medicine
Marta Ruiz
Icahn School of Medicine at Mount Sinai
See next page for additional authors
Let us know how access to this document benefits you
Follow this and additional works at: http://jdc.jefferson.edu/farberneursofp
Part of the Medicine and Health Sciences Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Recommended Citation
Unterwald, Ellen M; Page, Michelle E.; Brown, Timothy B; Miller, Jonathan S; Ruiz, Marta;
Pescatore, Karen A; Xu, Baoji; Reichardt, Louis French; Beverley, Joel; Tang, Bin; Steiner, Heinz;
Thomas, Elizabeth A; and Ehrlich, Michelle E, "Behavioral and transcriptome alterations in male and
female mice with postnatal deletion of TrkB in dorsal striatal medium spiny neurons." (2013).
Faculty papers Farber Institute for Neurosciences. Paper 23.
http://jdc.jefferson.edu/farberneursofp/23
Authors
Ellen M Unterwald, Michelle E. Page, Timothy B Brown, Jonathan S Miller, Marta Ruiz, Karen A Pescatore,
Baoji Xu, Louis French Reichardt, Joel Beverley, Bin Tang, Heinz Steiner, Elizabeth A Thomas, and Michelle E
Ehrlich
This article is available at Jefferson Digital Commons: http://jdc.jefferson.edu/farberneursofp/23
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Behavioral and transcriptome alterations in male
and female mice with postnatal deletion of TrkB
in dorsal striatal medium spiny neurons
Ellen M Unterwald1, Michelle E Page2, Timothy B Brown2, Jonathan S Miller1, Marta Ruiz3, Karen A Pescatore1,
Baoji Xu4, Louis French Reichardt5, Joel Beverley6, Bin Tang7, Heinz Steiner6, Elizabeth A Thomas7
and Michelle E Ehrlich2,3*
Abstract
Background: The high affinity tyrosine kinase receptor, TrkB, is the primary receptor for brain derived neurotrophic
factor (BDNF) and plays an important role in development, maintenance and plasticity of the striatal output
medium size spiny neuron. The striatal BDNF/TrkB system is thereby implicated in many physiologic and
pathophysiologic processes, the latter including mood disorders, addiction, and Huntington’s disease. We crossed a
mouse harboring a transgene directing cre-recombinase expression primarily to postnatal, dorsal striatal medium
spiny neurons, to a mouse containing a floxed TrkB allele (fB) mouse designed for deletion of TrkB to determine its
role in the adult striatum.
Results: We found that there were sexually dimorphic alterations in behaviors in response to stressful situations
and drugs of abuse. Significant sex and/or genotype differences were found in the forced swim test of
depression-like behaviors, anxiety-like behaviors on the elevated plus maze, and cocaine conditioned reward.
Microarray analysis of dorsal striatum revealed significant dysregulation in individual and groups of genes that may
contribute to the observed behavioral responses and in some cases, represent previously unidentified downstream
targets of TrkB.
Conclusions: The data point to a set of behaviors and changes in gene expression following postnatal deletion of
TrkB in the dorsal striatum distinct from those in other brain regions.
Keywords: TrkB.FL, Medium spiny neuron, Dorsal striatum, BDNF, DARPP-32
Brain-derived neurotrophic factor (BDNF) and its high
affinity tyrosine kinase receptor, TrkB, play important
roles in development, maintenance and plasticity of the
striatal output medium size spiny neuron (MSN). Eighty to
ninety percent of the BDNF in the striatum is anterogradely
transported from the cortex, and the remainder is derived
from the substantia nigra [1]. All MSNs express TrkB,
the primary receptor for BDNF, but TrkB is enriched in
dopamine D2-receptor (D2R)-expressing MSNs relative
to D1R-expressing MSNs [2-4]. TrkB is encoded by the
gene, Neurotrophic tyrosine kinase, receptor, type 2
(Ntrk2). There are two major TrkB isoforms, including
the full-length TrkB.FL containing the tyrosine kinase
domain, i.e. tk+, and a C-terminal truncated form, TrkB.T1,
lacking the catalytic tyrosine kinase domain. TrkB.T1 is a
dominant-negative receptor that inhibits TrkB.FL signaling,
but has many other functions, including as a signal transdu-
cing molecule [5].
The striatal BDNF/TrkB system is implicated in physio-
logic and pathophysiologic processes, e.g. mood disorders
and addiction, which present as primary diseases and as
disorders associated with neurodegenerative diseases,
including Alzheimer’s, Huntington’s and Parkinson’s dis-
ease. In addition, the system is directly implicated in striatal
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dysfunction and degeneration in Huntington’s disease.
Thus, the BDNF/TrkB system is a potential therapeutic
target in a myriad of clinical conditions. An emerging
aspect of the study of this system is the disparate, and
sometimes opposite, effects on behavior derived from its
manipulation in different brain regions, e.g. hippocampus
vs. ventral striatum [6]. Within the striatum, studies of
mood disorders and addiction focus largely on the ventral
portion, but evidence continues to accumulate supporting a
role for the dorsal striatum in these pathologies. The dorsal
striatum, including the caudate and putamen sub-regions,
is an intrinsic part of the circuitry of mood disorders [7],
and dorsal striatal dysfunction is particularly relevant in
compulsive drug seeking [8] and gating of alcohol intake
[9]. The dorsal striatum also obviously plays a key role in
Huntington’s and Parkinson’s disease.
We sought to examine the role of the TrkB receptor in
mature MSNs in adult male and female mice, with a
focus on behavior and gene expression. Previous studies
following constitutive and conditional deletion of the TrkB
receptor in all MSNs or subtypes [2,4,10,11] were based
largely on deletion during the prenatal period. In addition,
in the prior studies, TrkB deletion was not restricted to
MSNs. A limited number of studies utilizing viral-mediated
Cre recombinase, overexpression of TrkB, or siRNA knock-
down of TrkB in adult rodents have been published [12,13],
but none has compared males to females. To this end,
we used a mouse in which Cre-recombinase expression
is delayed until the postnatal period, and in which
within the forebrain, the transgene is restricted to MSNs
[14]. We found sexually dimorphic changes in animal
behaviors that are reflective of pathophysiology associated
with human mood disorders and drug abuse. We also
used a genome-wide assay of the TrkB-deleted dorsal stri-
atal transcriptome to identify downstream TrkB targets
which may be associated with alterations in behavior and
to compare these alterations to those that occur following
prenatal deletion of cortical BDNF.
Results
Creation of D9ΔTrkB mouse and assays of TrkB level
We previously created a transgenic mouse (aka D9-Cre)
using 9Kb of the Ppp1r1b gene to drive expression of
Cre-recombinase in postnatal striatal medium spiny neu-
rons [14]. D9-Cre was crossed with a floxed TrkB mouse
(aka fB), which deletes the signal peptide of TrkB. Import-
antly, the fB/fB homozygous mouse has a normal level of
TrkB [2]. Homozygote fB, heterozygote D9-Cre mice were
used for this study, and we refer to them as D9ΔTrkB.
Controls were fB/fB only without any expression of cre re-
combinase. On western blotting of protein from the dorsal
striatum, male and female fB/fB mice had equal levels
of TrkB.FL (Figure 1a, P > 0.05, not significant). Using
western blotting, RT-qPCR and in situ hybridization
with full-length TrkB-specific primers, we found that
TrkB mRNA and protein were decreased by 50% in the
dorsal striatum in males and females, and by 25-40% in
the ventral striatum/nucleus accumbens in D9ΔTrkB mice
compared to fB/fB controls. These data are consistent
with our previous report showing that D9-Cre directs
recombination in the majority of the dorsal MSNs,
with a lower level of recombination in the ventral striatum
[14]. The decrease in TrkB.T1 protein did not reach
significance in D9ΔtrkB mice (Figure 1b). Of note, stri-
atal interneurons express a higher level of TrkB than is
found in MSNs, and glia express a high level of TrkB.
T1 [3,5,15]. The D9-Cre transgene is not expressed in
either interneurons or glia, and hence the remaining TrkB
likely results from expression in these cell types, in
addition to pre-synaptic TrkB receptors on glutamatergic
terminals. Previous reports with early conditional dele-
tion of TrkB using Dlx5/6-Cre recombinase reported
an almost complete deletion of both FL and T1 TrkB
[2,4], but the percent decreases using more selective
Cre drivers or viral-mediated-Cre recombination were
similar to that which we observed [10,12].
D9ΔTrkB male and female mice have normal baseline
motor behavior
Each behavior assay was performed on a naïve cohort.
Pan-neuronal, prenatal deletion of TrkB usually leads to
early postnatal death, but the mice that survive for several
weeks display circling, hind limb clasping, dystonic-like
features, and ataxia. Selective early, prenatal striatal de-
letion leads to a failure of MSN development, and is also
associated with hind-limb clasping and hypoactivity
[2,4]. Life span and adult weight of D9ΔTrkB mice were
normal and the mice were free of spontaneous motor
abnormalities and hind limb clasping up to 24 months
of age. Although females of both genotypes had higher
activity counts than males, there were no genotype-
dependent differences in total activity, ambulatory ac-
tivity or stereotypy in 6-month-old male and female
D9ΔTrkB and fB/fB mice (Figure 1c). In addition, la-
tency to fall on rotarod testing was unchanged in adult
D9ΔTrkB mice indicating no effect of genotype on
motor coordination (data not shown).
D9ΔTrkB male and female mice display genotype- and
sex-dependent differences in depression- and
anxiety-like behaviors
Depressive- and anxiety-like behaviors were assayed in
naive cohorts of 6-month-old male and female mice.
The forced swim test was used to assess depression-like
behavior [16]. Mice were placed individually into a cylinder
of water for 6 minutes during which time activity was mea-
sured in terms of passive immobility or active swimming
and climbing. In this test, increasing periods of immobility
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are associated with a depression-like phenotype, whereas
clinically useful antidepressants reduce immobility [16].
Results of the forced swim test demonstrated that male
D9ΔTrkB mice had lower immobility scores versus male
fB/fB. One-way ANOVA revealed a significant effect of
genotype for the males (F[1,26] = 8.52; P < 0.01; Figure 2a),
indicating an anti-depressive phenotype, but no difference
for females.
To determine the effects of deletion of striatal MSN TrkB
on anxiety, mice were tested in the elevated plus maze [17].
Two-way ANOVA revealed a significant sex by genotype
interaction (F(1,29) = 4.279, P < 0.05; Figure 2b). D9ΔTrkB
males displayed lower anxiety-like behavior on the elevated
plus maze as shown by significantly greater time spent
in the open arms compared with control fB/fB male
mice (P < 0.05; Figure 2b;). D9ΔTrkB females did not
show this effect as there was no significant difference
between genotypes in the time spent in the open arms
of the elevated plus maze for the females (P > 0.50).
Cocaine conditioned reward
Conditioned place preference was used to measure the
rewarding effects of cocaine (10 mg/kg, ip) in D9ΔTrkB
versus fB/fB adult male and female mice. Two-way
ANOVA revealed a significant sex by genotype inter-
action (F(1,26) = 4.935, P < 0.05; Figure 2c). Male mice
showed a significant place preference for the cocaine-paired
environment with no significant differences between
genotypes. Females, however, showed a significant ef-
fect of genotype. Cocaine produced a larger place pref-
erence in D9ΔTrkB females than in fB/fB female mice
(P < 0.05). Further, fB/fB males showed a greater pref-
erence for the cocaine-paired environment than fB/fB
females (P < 0.05). These results suggest an increase in
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Figure 1 Baseline striatal TrkB level and locomotor activity in D9ΔTrkB mice. (a) Baseline levels of striatal TrkB.FL and TrkB.T1 are equal in
fB/fB male and female mice. Densitometric values were normalized to actin. Blot is representative of N = 6, p > 0.05 (t-test). (b) Relative to fB/fB,
D9ΔTrkB male and female mice demonstrate approximately a 50% decrease in striatal TrkB.FL (N = 3–4,*** P < 0.005, t-test). There is a trend
towards a small decrease in TrkB.T1 (N = 3, P = 0.06, t-test). Densitometric values were normalized to actin, and fB/fB levels were arbitrarily set to
equal 1. (c) Down-regulation of striatal MSN TrkB.FL does not alter baseline total activity, but there is a genotype-independent increase in activity
in female mice relative to males (N = 8-12/group, ** P < 0.01 two-way ANOVA for sex factor).
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cocaine reward upon TrkB deletion in the striatum se-
lectively in female mice.
Locomotor responses to acute and repeated administration
of cocaine in female fB/fB and D9ΔTrkB mice
Based on genotype- and sex-specific results in the cocaine
place preference assay, we investigated the response to
acute and repeated administration of cocaine in female
mice to analyze acute activity and stereotypy responses to
cocaine, and to determine if D9ΔTrkB female mice sensi-
tized to the motor-stimulating effects of repeated adminis-
tration of cocaine. Figure 2d shows total activity counts of
female D9ΔTrkB and fB/fB mice following the first saline
or cocaine (20 mg/kg, ip) injection. Two-way ANOVA
revealed a significant effect of genotype (F(1,18) = 16.96,
P = 0.0006), treatment (F(1,18) = 45.03, P < 0.0001), and
interaction (F(1,18) = 10.06, P = 0.0053). Cocaine produced
greater hyperactivity in female D9ΔTrkB mice as compared
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Figure 2 D9ΔTrkB male and female mice display genotype- and sex-dependent differences in depression- and anxiety-like behaviors
and in cocaine place preference. (a) In the forced swim test, male D9ΔTrkB mice had lower immobility scores versus male fB/fB, but there was
no difference for females (*P < 0.05 fB/fB vs D9ΔTrkB males, N = 10-18/group). (b) In the elevated plus maze, male D9ΔTrkB spent a greater
amount of time in the open arms versus male fB/fB, but there was no difference for females (*P < 0.05 fB/fB vs D9ΔTrkB males, N = 8-10/group).
(c) Cocaine produced a larger place preference in D9ΔTrkB females versus fB/fB females (*P < 0.05, N = 7/group). Males showed a place
preference for cocaine that was genotype-independent. fB/fB males showed a significantly greater place preference than fB/fB females
(#P < 0.05, N = 7-8/group). (d) Acute cocaine, 20 mg/kg, increased activity in females of both genotypes (*p < 0.05, ***P < 0.001 saline versus
cocaine, N = 5-6/group). Cocaine produced greater hyperactivity in female D9ΔTrkB mice versus fB/fB (### P < 0.001, N = 5-6/group). (e) Female
mice were injected with saline or cocaine, 20 mg/kg, for 5 days. After a 6-day drug-free period, a cocaine challenge injection, 15 mg/kg, produced
greater hyperactivity in D9ΔTrkB mice pretreated with cocaine versus fB/fB controls pretreated with cocaine (###P < 0.001, N = 5-6/group) In
addition, D9ΔTrkB mice pretreated with cocaine showed greater hyperactivity in response to the cocaine challenge than did D9ΔTrkB mice
pretreated with saline (**P < 0.01, N = 5–6), demonstrating that locomotor sensitization was greater in the D9ΔTrkB female mice.
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with female fB/fB controls (P < 0.001). When activity
was separated into ambulatory and stereotypy responses,
D9ΔTrkB female mice showed higher levels of both ambu-
latory and stereotypic activity following a cocaine injection
(P < 0.01 and P < 0.001, respectively; data not shown).
Next, female mice were injected with saline or cocaine,
20 m/kg ip, once daily for 5 days, which was followed by
a 6-day drug-free period. On day 12, all mice were chal-
lenged with a cocaine injection (15 mg/kg ip) and activity
recorded to test for the development of sensitization.
Two-way ANOVA showed a significant effect of genotype
(F(1,18) = 12.68, P = 0.0022) and treatment (F(1,18) = 15.42,
P = 0.001) for total activity (Figure 2e), D9ΔTrkB female
mice, but not control fB/fB females, showed behavioral
sensitization as evidenced by significantly greater hyper-
activity following the cocaine challenge on Day 12 in
D9ΔTrkB pretreated with cocaine than in D9ΔTrkB
pretreated with saline (P < 0.01). In addition, a genotype
effect was found in that D9ΔTrkB mice pretreated with
cocaine showed greater hyperactivity in response to the
cocaine challenge as compared with control mice pre-
treated with cocaine (P < 0.001). There were significant
genotype effects for both ambulatory (P < 0.05) and
stereotypic activity (P < 0.01) with D9ΔTrkB mice be-
ing the high responders in both cases (data not shown).
These results demonstrate a hyperactive phenotype of the
D9ΔTrkB female mice in response to acute and repeated
cocaine administration.
Alterations in gene expression in dorsal striatum in
D9ΔTrkB mice
Prenatal, conditional deletion of cortical BDNF using
Emx1-cre mediated recombination results in a myriad of
changes in the transcriptome [18] and changes in ex-
pression of selected genes have been identified follow-
ing prenatal deletion of TrkB throughout the striatum
or in specific MSN subtypes [2,4,10]. Genome-wide
assay of the transcriptome following deletion of striatal
TrkB at any age or in specific MSN subtypes has not
previously been reported, and we reasoned that chronic
down-regulation of TrkB in the mature MSN would alter
the transcription of multiple genes. In situ hybridization
of Ntrk2, Penk, Tacr1, Ppp1r1b and Pdyn mRNAs demon-
strated distinct patterns of regulation in male D9ΔTrkB
mice and the data are summarized in Table 1. Figure 3a
schematically shows dorsal striatal sub-regions that were
analyzed at the mid-level of the striatum, the level at
which all effects were maximal. In the sub-regions, Ntrk2
mRNA was decreased from 40-60%, with an overall de-
crease of 51% (fB/fB 19.7+/−1,7 vs D9ΔTrkB 10.0+/−1.2,
arbitrary units, P = 0.005). Penk mRNA was decreased
from 30-45% with an overall decrease of 38% (Figure 3b;
fB/fB 70.0+/−4.1 vs D9ΔTrkB 43.6+/−1.3, P < 0.001).
Ppp1r1b were decreased in the dorsal striatum, with a
medial-lateral gradient, maximal in the lateral region of the
middle level (fB/fB 44.0+/−0.5 vs D9ΔTrkB 37.6+/−1.0,
P = 0.004). In the same region, Tacr1 was decreased by
20% (fB/fB 61.7+/−3.7 vs. D9ΔTrkB 50.0+/−2.4, P = 0.04).
Pdyn was increased in D9ΔTrkB relative to fB/fB, significant
only on the middle level (fB/fB 19.2+/−1.1 vs D9ΔTrkB
26.1+/−2.1; P < 0.05). In the nucleus accumbens at +5.2 mm
rostral to the interaural line, Ntrk2 was decreased by 40%
(fB/fB 26.2+/−3.6 vs D9ΔTrkB 15.4+/−1.0, P = 0.02). A
lower level of Cre-mediated recombination in the nucleus
accumbens was most obvious when assaying downstream
targets of TrkB deletion, as Penk was decreased by only
18% (fB/fB 75.6+/−3.8 vs D9ΔTrkB 61.7+/−2.5, P = 0.02),
and Tacr1, Ppp1r1b and Pdyn were unaltered in the
nucleus accumbens.
RT-qPCR assays were then performed with samples de-
rived from the dorsal striatum of male mice (Figure 3c).
Since the entire dorsal striatum was dissected for this
analysis, it is important to note that sub-region-specific
alterations within the striatum were possibly masked.
For example, although Ppp1r1b/DARPP-32 is markedly
up-regulated by BDNF during development [19] and was
decreased in D9ΔTrkB dorsolateral striatum as measured
by in situ hybridization, it was unchanged as measured
by RT-qPCR. Given that TrkB is enriched in dopamine
receptor type 2 (D2R) MSNs relative to dopamine re-
ceptor type 1 (D1R) MSNs [2], we performed a screen
of transcripts that distinguish between MSN subtypes,
e.g. direct pathway D1R neurons, indirect pathway
D2R neurons, and markers of patch and matrix MSNs
(Figure 3c). We found that levels of Drd1 and Drd2
mRNAs were unchanged in dorsal striatum of male
D9ΔTrkB mice. The A2ar/adenosine receptor type 2
mRNA, which co-localizes with D2R and not with D1R,
and subunits of the NMDA receptor were also unchanged.
Although morphometric studies were not the focus of this
study, the D9ΔTrkB striatum appeared smaller and the
lateral ventricles larger than in fB/fB control mice. Normal
A2ar mRNA level suggests that death of D2R neurons
is not excessive, but as BDNF is required for postnatal
growth of MSN dendritic complexity and spine density
[20], such deficits could contribute both to a decrease
Table 1 Summary of gene expression changes as
determined by in situ hybridization (percent change
in D9ΔTrkB relative to fB/fB)
Gene ID Dorsal striatum Ventral striatum
(mRNA) (caudate-putamen) (nucleus accumbens)
Ntrk2 (−) 51%, P < 0.01 (−) 40%, P < 0.05
Penk (−) 38%, P < 0.001 (−) 18%, P < 0.05
Ppp1r1b (lateral) (−) 15%, P < 0.01 No change
Tacr1 (lateral) (−) 20%, P < 0.05 No change
Pdyn (+) 30%,P < 0.05 No change
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in striatal size and striatal dysfunction. Further work is
required to determine whether this apparent size differ-
ence is significant, and if so, its origin. Consistent with the
in situ hybridization data, Penk, also enriched in D2R
indirect pathway MSNs, was markedly decreased, as was
Calb1/calbindin, which is enriched in the matrix compart-
ment. Also consistent with the in situ hybridization, Pdyn,
enriched in D1R MSNs and the striosome/patch com-
partment [21], strongly trended upwards (P = 0.07).
Cnr1, or cannabinoid receptor 1, is present in both
D1R and D2R neurons and strongly trended downwards
(P = 0.07). These data suggest that genes expressed in
MSNs and regulated by TrkB are not relegated to a
specific MSN subtype.
We next performed a microarray analysis of baseline
gene expression in female dorsal striatum of fB/fB and
D9ΔTrkB mice (N = 4/genotype). There were 1749 tran-
scripts that were altered at the P < 0.05 level of significance
(Additional file 1: Table S1). Importantly, there was only
one discrepancy for the transcripts assayed in Figure 3c, as
Calb1 mRNA was unchanged by microarray. Calb1 mRNA
was, however, decreased in female D9ΔTrkB striatum by
over 50% when assayed by RT-qPCR (Figure 4a). We
focused on the 325 transcripts dysregulated in D9ΔTrkB
mice at P value less than 0.005 (Additional file 1: Table S1),
in order to identify candidate genes potentially relevant to
behavioral alterations described herein. Of these, 93 were
up-regulated following MSN TrkB deletion, and 260 were
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Unterwald et al. Molecular Neurodegeneration 2013, 8:47 Page 6 of 14
http://www.molecularneurodegeneration.com/content/8/1/47
down-regulated. Included amongst those that we validated
in female mice by RT-qPCR are Vgf, Egr1, Lynx2, Per2,
Ryr1 and Slit2 (Figure 4a), chosen in large part for their
known or hypothesized associations with behaviors assayed
in this study and/or synaptic plasticity. Of note, several of
these have not previously been associated with the BDNF/
TrkB signal transduction system, e.g. Per2. Ntrk3/TrkC was
significantly down-regulated, indicating that not only does
this neurotrophin receptor not compensate for the knock-
down of Ntrk2/TrkB, but that it is a direct or indirect
downstream target of Ntrk2 and may contribute to the
alterations following deletion of MSN TrkB.
We interrogated the microarray data to identify path-
ways and functional classes over-represented in the list
of altered transcripts. Using GOEAST and DAVID at both
P < 0.005 and 0.01 levels of significance, enrichment and
144 181 2954
BDNF KO 0.05 (n=3098) TrkB CRE 0.005 (n=325)
fB/fB females
D9 TrkB
a
b
c
fB/fB males
D9 TrkB
D9
Figure 4 Microarray analysis of dorsal striatal samples from female D9ΔTrkB mice reveals widespread alterations in gene expression
(see Table 2). (a) RT-qPCR assay of Ryr1, Slit2, Egr1, Ntrk3, Vgf, Per2, and Lynx2 mRNAs validated the results of the microarray analysis, whereas
assay of Adra2 mRNA did not show a difference between genotypes (N = 4/genotype; * P < 0.05,**P < 0.01,***P < 0.001). (b) RT-qPCR assay of Ryr1,
Per2, Ptpn5 and Vgf mRNAs in striatal samples from male mice (N = 4/genotype) showed reductions in transcripts similar to those observed in
samples from females (**P < 0.01,***P < 0.001). (c) Venn diagram illustrating that of the top 325 genes with mRNA levels altered at the P < 0.005
level in D9ΔTrkB mice, only 144 were altered in BDNF-null mice (from [18]) at the least stringent level of significance, P < 0.05.
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gene clusters were found in the following Gene Ontology
(GO) classifications: metal ion transport, voltage gated ion
channel activity, and metal ion and cation membrane
transporter activity. These pathways and molecules are as-
sociated with intracellular calcium regulation and signal
transduction, and some are known to be required for
BNDF activity [22]. Amongst them is the aforementioned
Calb1 and Ryr1, and also Calb2, Hpcal4, Cacng5, and
Homer1, the latter known to be associated with BDNF
activity and plasticity [23].
We next used Ingenuity Systems Pathways Analysis to
examine canonical pathways that were significantly corre-
lated with genes differentially expressed in the striatum of
D9ΔTrkb mice. Top pathways included Protein kinase A
signaling, G-protein signaling, CXCR4 signaling and RAR
activation (Table 2). The Protein kinase A signaling path-
way contained Ptpn5/STEP, a striatal-enriched gene known
to be associated with responses to drugs of abuse and stress
[24], and not previously identified as being regulated by
BDNF/TrkB. In addition, there were alterations in several
genes encoding members of the cAMP-mediated signaling
pathway, e.g. Rgs2 and Adcy1, and other signal transduction
pathways, including CREB and ErbB2-ErbB3 (Table 2).
Transcripts for multiple immediate early genes and other
transcription factors or co-regulators were found to be
significantly altered in D9ΔTrkB mice, implying that the
dysregulated genes are likely comprised of direct and indi-
rect targets of TrkB signaling. These include several imme-
diate early genes and transcription factors associated with
plasticity and responses to drugs of abuse, e.g. Arc, Egr1,
2 and 4, and known to be up-regulated by BDNF and/or
required for its downstream gene regulation [25,26]. Others
include Dusp6, Pou3f1, Klf5, Calcoco1, and Ppargc1α. Inter-
estingly, Ppargc1α is up-regulated, contrary to what would
be anticipated by studies in Huntington disease models in
which cortical BDNF, striatal TrkB, and Ppargc1α are all
down-regulated (reviewed in [27]).
An obvious question is whether sexual dimorphism in
gene regulation may account for sex-dependent behavioral
differences in D9ΔTrkB mice. Although we did not per-
form a second microarray analysis on male mice, we did
assay levels of several potentially relevant transcripts that
we had assayed in female mice either by qPCR or as part of
the microarray analysis, including Ptpn5 (striatum-enriched
protein tyrosine phosphatase), Ryr1(ryanodine receptor 1),
Vgf (nerve growth factor inducible), and Per2 (periodic
circadian clock 2). All four transcripts were altered in
the same direction and magnitude as in the female mice
(Figure 4b).
Discussion
This is the first report to directly address the effects of
postnatal knockdown of MSN TrkB throughout the
striatum, but with a focus on the dorsal portion, i.e.
caudate-putamen. Previous studies utilized mice express-
ing the Dlx5/6-, Drd1- and Drd2-cre recombinase drivers,
and thereby deleted TrkB in the prenatal period in both
dorsal and ventral striatum and in cell types other than
MSNs. Viral-mediated manipulation of FL or T1 TrkB in
the adult mouse has focused on the ventral striatum. By
using a promoter that fortuitously directs expression
of Cre-recombinase to postnatal MSNs, the mice studied
herein are unlikely to have marked developmental deficits
and their attendant molecular compensations. We found
that 1) D9ΔTrkB mice have normal lifespan and baseline
behavior; 2) there is a sexually dimorphic effect on per-
formance in the forced swim test and elevated plus maze,
detectable only in D9ΔTrkB males; 3) the response to co-
caine in D9ΔTrkB mice is also sexually dimorphic, with an
increased genotype-dependent preference for cocaine in
females; 4) female D9ΔTrkB mice show increased locomotor
sensitization to chronic cocaine relative to fB/fB controls;
and 5) there is a marked effect of TrkB down-regulation on
baseline gene expression in the dorsal striatum.
Sexual dimorphism in the response to physiological
and behavioral stress, and the direct relationship of this
response to the development of mental illness, may be
organizational and/or activational (reviewed in [28,29].
The caudate-putamen is a sexually dimorphic brain region,
based on sex-specific differences in size and in the number
of gonadal hormone receptors [30]. In our study, female
mice were group housed, with D9ΔTrkB and fB/fB mice in
the same cages. Female mice were not ovariectomized, and
estrus cycle was not determined prior to or after testing.
It is highly unlikely therefore, that the observed sexual
dimorphism was dependent on circulating sex steroid,
suggesting organizational effects independent of circulating
hormone levels. This hypothesis is being tested in ongoing
experiments. Our study contributes to the emerging litera-
ture on sexual dimorphism in the neurotrophic system.
There are interactions between sex steroid hormones and
BDNF in many species, organs, and brain regions, which
may modulate transcription, translation, and/or strength of
signal transduction of BDNF and TrkB [31-35]. Our data
imply that adult males may be more sensitive to a decrease
in striatal TrkB level, but perhaps surprisingly, the changes
were not detrimental per se, and may even be considered
beneficial. Data from studies of whole brain and/or
hippocampus [36-38] largely show that a decrease in the
level of BDNF, and by extension TrkB, generally leads to
an increase in depressive- and anxiety-related behaviors
or in females, a lower threshold for stress-induced anhe-
donic behavior. An important exception in the literature
is a strong trend to a decrease in anxiety-related behavior
in female mice following forebrain deletion of BDNF [37].
On the other hand, BDNF in the nucleus accumbens is
pro-depressant and an experimental decrease in BDNF
or an increase in TrkB.T1 in the nucleus accumbens is
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“anti-depressant” in male mice [6]. A decrease in depressive-
and anxiety-related behaviors in male mice following striatal
TrkB knockdown is also consistent with a recent report of
similar effects following administration of a TrkB antagonist
[39]. Thus, albeit highly speculative, a decrease in TrkB
activity in the striatum appears to “override” a decrease
in the hippocampus, and knockdown in the dorsal stri-
atum is required for an effect on anxiety-related behav-
iors, which are not altered by knockdown of the BDNF/
TrkB system restricted to the nucleus accumbens, or to
D1R or D2R MSNs. It is therefore important to note
that in studies utilizing forebrain deletion of BDNF [37,38],
the amount of BDNF transported from the ventral teg-
mental area to the nucleus accumbens may not have
been altered. Together, these data encourage further
investigation into the role of the dorsal striatum in de-
pression and anxiety, and the apparent differences that
arise from whole brain and region-specific manipula-
tion of BDNF or TrkB.
The question of the regional and neuronal subtype
origins of behavioral changes is also relevant to the re-
sponses to cocaine observed in this study. It remains
Table 2 Top canonical pathways associated with TrkB deletion in mouse striatal MSNs
Canonical pathway: -log (p-value): Ratio: Molecules:
Thrombin signaling 2.69E + 00 5.34E-02 ARHGEF10, MPRIP, GATA1, RHOT2, ADCY1, GNB5, CAMK1G, HRAS,
PRKCH, GNG7, PRKCB
Protein kinase A signaling 2.63E + 00 4.28E-02 SHH, PTPN7, PTPRE, SMAD3, DUSP6, GNB5, PTPN5, TCF7, GNG7, PTEN,
ADD3, ADCY1, SMAD4, RYR1, PRKCH, CDC16, PRKCB
Galpha(i) signaling 2.44E + 00 6.06E-02 GRM8, NPY1R, ADCY1, GNB5, HRAS, ADRA2C, STAT3, GNG7
Prolactin signaling 2.39E + 00 7.50E-02 HRAS, PRKCH, STAT3, SOCS5, TCF7, PRKCB
CXCR4 signaling 2.36E + 00 5.36E-02 EGR1, RHOT2, ADCY1, GNB5, HRAS, PRKCH, ELMO1, GNG7, PRKCB
Glutamate receptor signaling 2.18E + 00 7.25E-02 GRM8, SLC1A1, HOMER1, GNG7, GRIK1
Galpha(s) signaling 2.11E + 00 5.79E-02 RGS2, ADD3, ADCY1, GNB5, RYR1, HTR6, GNG7
Cell cycle: G1/S checkpoint regulation 2.06E + 00 7.58E-02 PA2G4, HDAC8, SMAD3, SMAD4, CDKN1B
Beta-adrenergic signaling 2.04E + 00 5.71E-02 ADCY1, GNB5, HRAS, PRKCH, GNG7, PRKCB
Phospholipase C signaling 2.04E + 00 4.23E-02 ARHGEF10, MPRIP, HDAC8, RHOT2, ADCY1, GNB5, ITGA5,
HRAS, PRKCH, GNG7, PRKCB
Neuregulin signaling 2.00E + 00 5.88E-02 ITGA5, HRAS, PRKCH, CDKN1B, PTEN, PRKCB
G Beta gamma signaling 2.00E + 00 5.13E-02 ADCY1, GNB5, HRAS, PRKCH, GNG7, PRKCB
RAR activation 1.98E + 00 4.76E-02 SMAD3, ADCY1, SMAD4, PRKCH, ERCC2, PTEN, PPARGC1A, RBP4, PRKCB
Virus entry via endocytic pathways 1.97E + 00 6.06E-02 ITGA5, TFRC, HRAS, PRKCH, CXADR, PRKCB
Chronic myeloid leukemia signaling 1.86E + 00 5.71E-02 PA2G4, HDAC8, SMAD3, SMAD4, HRAS, CDKN1B
Glioma signaling 1.84E + 00 5.36E-02 PA2G4, CAMK1G, HRAS, PRKCH, PTEN, PRKCB
Axonal guidance signaling 1.77E + 00 3.42E-02 SHH, GNB5, HRAS, SEMA6B, ITGA5, FZD1, SLIT2, GIT1, GNG7, NTNG1,
SEMA3A, SUFU, BAIAP2, ABLIM2, PRKCH, PRKCB
Breast cancer regulation by stathmin1 1.73E + 00 4.35E-02 ARHGEF10, ADCY1, GNB5, CAMK1G, HRAS, PRKCH, CDKN1B, GNG7, PRKCB
Molecular mechanisms of cancer 1.60E + 00 3.44E-02 SHH, PA2G4, SMAD3, RHOT2, HRAS, FZD1, ARHGEF10, SUFU, ADCY1,
SMAD4, PRKCH, CDKN1B, PRKCB
Renin-angiotensin signaling 1.60E + 00 4.80E-02 ADCY1, HRAS, SHC3, PRKCH, STAT3, PRKCB
CREB signaling in neurons 1.56E + 00 3.94E-02 GRM8, ADCY1, GNB5, HRAS, PRKCH, GNG7, GRIK1, PRKCB
Androgen signaling 1.55E + 00 4.17E-02 SMAD3, GNB5, PRKCH, ERCC2, GNG7, PRKCB
ErbB2-ErbB3 signaling 1.51E + 00 6.67E-02 HRAS, STAT3, CDKN1B, PTEN
Calcium signaling 1.48E + 00 3.79E-02 TNNT1, HDAC8, CAMK1G, TPM2, RYR1, TRPC4, CASQ2, GRIK1
14-3-3-mediated signaling 1.45E + 00 4.96E-02 STK11, TSC2, HRAS, PRKCH, CDKN1B, PRKCB
P2Y purigenic receptor signaling pathway 1.42E + 00 4.35E-02 ADCY1, GNB5, HRAS, PRKCH, GNG7, PRKCB
PTEN signaling 1.42E + 00 4.44E-02 INPP5F, FLT1, ITGA5, HRAS, CDKN1B, PTEN
IL-8 signaling 1.41E + 00 3.90E-02 FLT1, RHOT2, GNB5, HRAS, PRKCH, IRAK3, GNG7, PRKCB
cAMP-mediated signaling 1.41E + 00 4.02E-02 RGS2, GRM8, NPY1R, DUSP6, ADCY1, CAMK1G, ADRA2C, HTR6, STAT3
Microarray data were analyzed through the use of IPA (Ingenuity® Systems, www.ingenuity.com).
The p-value was calculated using the right-tailed Fisher Exact Test, considering the number of molecules participating in a given pathway and the total number of
molecules associated with that pathway in Ingenuity’s knowledge base.
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difficult to parse out exclusive functions for the ventral
and dorsal striatum, but the reward mechanism as
measured by preference for cocaine in the conditioned
place preference paradigm is largely attributed to the
ventral striatum whereas acute locomotor activity and
locomotor sensitization to cocaine are primarily medi-
ated by the dorsal striatum [40-43]. The dorsal striatum,
however, is strongly implicated in reward mechanisms
based on habit learning theories of addiction [8], as
particularly demonstrated in models of an escalation
in cocaine seeking that implicate BDNF signal trans-
duction [44,45]. Deletion of TrkB in dorsal and ventral
striatal D1R MSNs results in increased preference for
cocaine and increased sensitization in male mice,
whereas deletion in D2R MSNs (and presumably some
interneurons) has opposite effects [10]. A decrease in
accumbal TrkB in both D1R and D2R MSNs reduces
cocaine reward [12,13]. Prenatal deletion of TrkB in
Penk-containing MSNs results in baseline hyperlocomo-
tion and an enhanced locomotor response to cocaine
in males, but sensitization and cocaine preference were
not assayed in this study [11]. Our data imply that in
females, the role of the D1R MSNs overrides that of
the D2R MSNs when TrkB is down-regulated in both
MSN subtypes during the postnatal period. They may
also suggest that accumbal TrkB is a limiting factor in
previously reported responses, as we saw a lesser and
more variable decrease in TrkB in this region. These
data therefore reinforce the relevance of the dorsal
striatum and the difficulty in attributing behaviors spe-
cifically to the dorsal or ventral regions [42], and high-
light the need for increased attention to female models
of disease.
We identified many gene expression abnormalities that
were associated with TrkB down-regulation in MSNs.
Of the 325 genes identified in the present study with
transcript levels altered at P < 0.005, only 144 of these
transcripts have been reported to be altered in BDNF-null
mice at the least stringent level of significance, P < 0.05
[18] (Figure 4c). These data suggest that the MSN
TrkB receptor is mediating a distinct subset of behav-
ioral and physiological effects elicited by BDNF in the
striatum. In addition, it is possible that prenatal dis-
ruption of striatal BDNF/TrkB signaling may produce
more widespread alterations of the transcriptome than
postnatal down-regulation of BDNF/TrkB signaling,
although expression of BDNF in the cortex is low in
the prenatal period. Finally, it is possible that the broader
disruption of the striatal transcriptome following dele-
tion of BDNF represents other cell types and/or non-
cell-autonomous effects on MSN transcription. Although
not directly comparable, it is interesting to note that of
the 20 transcripts with the greatest fold-change in our
microarray analysis, only one is altered in the nucleus
accumbens following cre-mediated deletion of BDNF
in the adult ventral tegmental area [46], and several
transcripts with lower fold-change, e.g. Per2 and Egr3,
are altered in opposite directions.
It is tempting, but premature, to assign changes in
behavior that we measured in the D9ΔTrkB mice to
the observed altered gene expression patterns, i.e. metal
ion transport or second messenger signaling; however
it is possible that chronic, baseline alterations may
have different effects than drug-induced alterations. It
is also likely that changes in individual genes may
antagonize each other, and so effects of transcripts that
were studied in isolation may not be as pertinent when
they are altered as part of a wider effect on the tran-
scriptome. For example, Per2 is not a known target of
BDNF/TrkB, and an isolated reduction in Per2 is predicted
to increase cocaine preference [47], but only females
displayed a genotype-dependent difference in cocaine
preference. Differences in regional effects are also im-
portant. Strikingly, a decrease in Vgf peptide in the
hippocampus is strongly associated with pro-depressant
effects [48], yet male D9ΔTrkB mice display anti-
depressant activity despite a 60% decrease in Vgf in the
striatum. It thus also remains to be determined whether
alterations in the transcriptome are sexually dimorphic,
given that our gene expression comparison between
sexes was limited. The striatum displays a higher num-
ber of sex-biased genes than do the hippocampus and
cortex, including in the expression of Ntrk3 and Pdyn
[49,50]. Protein kinase A signal transduction is also altered
in a sexually dimorphic manner after self-administration
of cocaine, an effect that could be synergistic with chronic
changes in expression of proteins whose activity is regu-
lated by phosphorylation, e.g. Ppp1r1b/DARPP-32 [51].
Finally, the list of striatal genes dysregulated following
deletion of TrkB includes genes that are expressed at
sexually dimorphic levels in other brain regions, but remain
to be studied in the striatum, e.g. the aforementioned Per2.
Thus, the microarray data provide important and novel
leads for targeted study of genetic and epigenetic regulation
of sexual dimorphism in the striatum, particularly as related
to the BDNF/TrkB system.
Conclusions
In summary, knockdown/deletion of adult striatal, MSN
TrkB results in alterations of behavior and gene expres-
sion which differ qualitatively and quantitatively from
those that occur following prenatal deletion. Changes in
behaviors in response to stressful situations or drugs are
sexually dimorphic, but it remains to be determined
whether the same is true for prenatal deletion and gene
expression. The data encourage further investigation
into the role of the dorsal striatum and individual TrkB
targets in these behaviors.
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Methods
Genotyping
Mice were group housed, given ad libitum access to food
and water, and housed under a 12-hour light/dark cycle.
All animal procedures were conducted in accordance
with the National Institute of Health Guidelines for the
Care and Use of Experimental Animals and were approved
by the Institutional Animal Care and Use Committee at
the Icahn School of Medicine at Mount Sinai. Mice with a
floxed TrkB allele (fB) [2] and the D9-Cre recombinase
mouse [14] have been previously described. Both strains
were in the C57BL/6 J background. Tail DNA was pre-
pared from three week old mice. To distinguish between
floxed TrkB heterozygote and homozygote mice, the
sequence of the PCR primers were as follows: Trkb-n2:
ATG TCG CCC TGG CTG AAG TG; Trkb-c8: ACT
GAC ATC CGT AAG CCA GT; Trkb-c7: GAT GAT
TTC TAG CCT TTT CTG G. TrkB-n2 and Trkb-c8
amplify a 369 bp product from the wild type TrkB allele,
whereas Trkb-n2 and Trkb-c7 amplify a 245 bp product
from the fB allele. Cre recombinase is detected using a
second set of sequence-specific primers [14]. D9-Cre/fB
was crossed with fB/fB, which has a normal level of
TrkB in the homozygous state [2]. We refer to fB/fB
mice expressing D9-cre as D9ΔTrkB. Six to ten month
old mice were used for this study.
Western blotting
Protein levels were measured by western blot analysis of
protein extracted from regionally dissected brain tissue.
Soluble protein was extracted from tissue in 20 mM Hepes
(pH 7.6), 150 mM NaCl, 0.5 mM EDTA, and 0.5% Triton
X-100, supplemented with 1X Complete protease inhibitor
cocktail (Roche Diagnostics GmbH, Mannheim, Germany),
1 mM PMSF, 50 mM NaF, and 1 mM Na-orthovanadate.
Protein levels in the extracts were determined using the
Bio-Rad DC Protein Assay. Antibodies used included anti-
TrkB (1:1000) (BD Biosciences, Sparks, MD, USA) and
anti-β-actin (1:1000, Sigma, St. Louis, MO). Blots were
developed and visualized using the Fujifilm LAS-4000
Plus Gel Documentation System and Reader (Fujifilm
Holdings Corporation, Tokyo, Japan). Densitometric values
were obtained using Multi Gauge software for analysis
(Fujifilm Lifesciences, Tokyo, Japan).
Forced Swimming Test (FST)
Mice were subjected to the swim chamber after an accli-
mation period (2 hours) in the staging area outside of the
testing room. Mice were placed individually into a glass
cylinder (46 cm tall x 21 cm in diameter) filled with water
(23-25°C water) to a depth of 15 cm for six minutes.
The depth is deep enough so that mice cannot support
themselves by placing their paws on the base of the cy-
linder. A cylinder of this diameter was used because
the larger swimming area has been reported to increase
the predictive validity of the mouse FST [52]. The ex-
periment was videotaped from above and scored later
by a rater blind to the genotype. The total duration of
immobility during the last 4 min of the test was deter-
mined from videotapes.
Elevated plus maze
The elevated plus maze was used to measure anxiety-like
behaviors. The mouse elevated plus maze (San Diego
Instruments, San Diego, CA) consists of four equal-sized
runways (12 inches long and 2 inches wide) laid-out in
the shape of a plus sign and elevated off the ground by
15 inches. Two of the arms are enclosed by solid walls,
6 inches high on the long sides (closed arms), whereas
the other two arms have no sides (open arms). A ledge
(1/8 inch high) is present around the perimeter of the
open arms of the maze. Test room lighting was adjusted
such that open arm light levels were w200 lux and closed
arm light levels were w160 lux. On test day, mice were ac-
climated to the room for 60 minutes prior to testing. Each
mouse was placed on the center maze and their behavior
was recorded for 10 minutes. The videotapes were scored
at a later time by a person blind to the genotype. The num-
ber of entries into the open and closed arms and the time
spent in each arm were measured. An entry was counted
when the superior portion of the mouse including the head
and neck, the shoulders, the forelimbs and forepaws, and
the thoracic region moved into an arm.
Locomotor activity
Activity was measured using the Digiscan D-Micropro
automated activity monitoring system (Accuscan, Inc.,
Columbus, OH). The activity monitors consist of transpar-
ent plastic boxes (45x20x20 cm) set inside metal frames
that are equipped with 16 infrared light emitters and detec-
tors. The number of photocell beam breaks is recorded by
a computer interface in 5 minute bins. Mice were placed
into the activity monitors and activity was recorded for 30
minutes during acclimation to the chambers. After 30
minutes, cocaine (20 mg/kg ip) or saline (3 ml/kg ip)
was administered and mice were immediately returned
to the activity monitors for 60 additional minutes of activity
measurement. This was repeated once daily for 5 days.
After a 6-day drug-free period, all mice were injected with
cocaine (15 mg/kg ip) and activity was measured as before
in order to test for behavioral sensitization.
Conditioned place preference
Conditioned place preference was performed using a
two compartment apparatus. The two compartments
were of equal size but one had solid black walls and a
smooth floor whereas the other compartment had black
and white vertical striped walls and a rough floor. There
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was a removable wall between the two compartments of
the apparatus. Mice were placed in the apparatus with
free access to both compartments in a 30 minute pretest
session. Time in each compartment was measured. Mice
were conditioned for 30 minutes once daily for 4 days. On
days 1 and 3, mice were injected with cocaine (10 mg/kg ip)
and confined to one compartment. On days 2 and 4, mice
were injected with saline (3 ml/kg ip) and confined to the
other compartment in a counterbalanced design. The
test session occurred 24 hours after the last conditioning
session and lasted 30 minutes. During the test session, mice
were placed into the apparatus with the wall between the
compartments removed, identical to the pretest, and time
spent in each compartment recorded. Preference scores are
reported as time in the cocaine-paired compartment after
conditioning minus time in the same compartment prior to
conditioning in seconds.
In situ hybridization
Briefly [53], the mice were killed with CO2, and their brains
were rapidly removed and frozen in isopentane cooled on
dry ice. Brains were stored at −20°C until cryostat section-
ing. Coronal sections (12 μm) were thaw-mounted onto
glass slides (Superfrost/Plus; Daigger, Wheeling, IL, USA),
dried on a slide warmer and stored at −20°C. Tissue
sections were fixed in 4% paraformaldehyde/0.9% saline for
10 min at room temperature, incubated in a fresh solution
of 0.25% acetic anhydride in 0.1 M triethanolamine/0.9% sa-
line (pH 8.0) for 10 min, dehydrated, defatted for 2X5 min
in chloroform, rehydrated, and air-dried. The slides were
then stored at −30°C until hybridization. Oligonucleotide
probes (48-mers; Life Technologies, Rockville, MD, USA)
were labeled with [35S]-dATP. The probes had the fol-
lowing sequence: for Tacr1/substance P, complementary
to bases 20–67, GenBank accession no. M68909; Penk/
enkephalin, bases 304–351, M13227; Pdyn/dynorphin, bases
807–854, AF026537; Ntrk2/TrkB, bases 733–780, NM
008745; Ppp1r1b/DARPP-32, bases 1253–1300, BC031129.
Striatal gene expression was determined in the nucleus
accumbens (total area, at ~5.2 mm rostral to the interaural
line [54]; and in the mid-level striatum (total area and med-
ial, central, lateral and ventral sectors; 4.2 mm rostral to the
interaural line; Figure 3a). Gene expression was measured
by densitometry (NIH Image; Wayne Rasband, NIMH) on
film autoradiograms.
Statistics
Statistical analysis was conducted using GraphPad software
(GraphPad Software, La Jolla, CA). In the case of compari-
son between genotypes, unpaired two-tailed Student t-test
was used. One-way ANOVA or two- way ANOVA with sex
and genotype or drug and genotype factors were used to
analyze the behavioral data. Bonferroni post-hoc compari-
sons were used with significant ANOVAs. Unpaired t-test
was used to analyze western blot, in situ hybridization
and RT-qPCR data. Results were considered significant
when P < 0.05.
Microarray analysis
Total RNA was extracted from the striatum of fB/fB and
D9ΔTrkB transgenic mice using the Nucleospin RNA kit
(BD Biosciences, San Jose, CA). RNA quantity was assessed
with Nanodrop (Nanodrop Technologies) and quality with
the Agilent Bioanalyzer (Agilent Technologies). Total RNA
(200 ng) was amplified, biotinylated and hybridized on
Illumina Mouse_8_V2 Beadchips, querying the expression
of ~22,000 Refseq transcripts, as per manufacturer’s
protocol. Slides were scanned using Illumina BeadStation
and signal extracted using Illumina BeadStudio software
(Illumina, San Diego CA). Raw data was analyzed as previ-
ously described using Bioconductor packages. Quality as-
sessment was performed looking at the inter-array Pearson
correlation and clustering based on top variant genes was
used to assess overall data coherence. Contrast analysis of
differential expression was performed using the ‘limma’
package [55]. After linear model fitting, a Bayesian estimate
of differential expression was calculated. Data analysis
was aimed at identifying transcriptional changes in the
D9ΔTrkB compared to fB/fB mice using different uncor-
rected p-value cut-offs ranging from p < 0.001 to p < 0.05.
Pathway analyses
Gene Ontology (GO) terms were identified using the
Database for Annotation, Visualization and Integrated
Discovery (DAVID) (http://david.abcc.ncifcrf.gov/) to
understand the potential biological relevance of differ-
entially expressed genes. Canonical pathway analysis
was performed using Ingenuity Systems Pathway Analysis
(http://www.ingenuity.com).
Additional file
Additional file 1: Table S1. Genes differentially expressed in striatum of
D9ΔTrkB mice at P < 0.05.
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